{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-312912","form_type":"8-K/A","ticker":"DMRA","cik":"0001800315","company_name":"Damora Therapeutics, Inc.","filed_at":"2025-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.495605+00:00","generated_at":"2026-05-16T13:48:57.286913+00:00","sec_items":["5.03","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Galecto corrects Series C Preferred Stock authorization from 43,855 to 43,882 shares","bullets":["Filed Certificate of Correction on Dec 5, 2025 to fix inadvertent error in Series C Preferred Stock designation.","Authorized shares revised to 43,882 from incorrectly stated 43,855; no other terms changed.","Amendment amends 8-K originally filed Nov 10, 2025; restated certificate attached as Exhibit 3.3."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-312912","json":"https://secwatch.observer/filing/0001193125-25-312912.json","markdown":"https://secwatch.observer/filing/0001193125-25-312912.md","text":"https://secwatch.observer/filing/0001193125-25-312912.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800315/000119312525312912/0001193125-25-312912-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800315/000119312525312912/glto-20251110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:48:57.286913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6014aab242d864cd1c420a33fa299071699b4c3b","claim":"Damora Therapeutics, Inc.: Corrected authorized shares of Series C Preferred Stock from 43,855 to 43,882 (effective 2025-12-05).","evidence_excerpt":"On December 5, 2025, the Company filed with the Delaware Secretary of State a Certificate of Correction (the “Certificate of Correction”) to the Certificate of Designation of Series C Preferred Stock to correct an inadvertent error in the number of shares of Series C Non-Voting Convertible Preferred Stock, par value $0.00001 per share (the “Series C Preferred Stock”), that the Company is authorized to issue by modifying Section 2 of the Certificate of Designation of Series C Preferred Stock to correctly state that the number of authorized shares of Series C Preferred Stock is 43,882 shares instead of 43,855 shares.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312525312912/0001193125-25-312912-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-12-05"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}